European Journal of Medicinal Chemistry p. 359 - 371 (2018)
Update date:2022-08-05
Pati, Maria Laura
Niso, Mauro
Spitzer, Dirk
Berardi, Francesco
Contino, Marialessandra
Riganti, Chiara
Hawkins, William G.
Abate, Carmen
The aggressiveness of pancreatic cancer urgently requires more efficient treatment options. Because the sigma-2 (σ2) receptor was recently proposed as a promising target for pancreatic cancer therapy, we explored our previously developed multifunctional thiosemicarbazones, designed to synergistically impair cell energy levels, by targeting σ2 and P-gp proteins and chelating Iron. A deconstruction approach was herein applied by removing one function at a time from the potent multifunctional thiosemicarbazones 1 and 2, to investigate the contribution to cytotoxicity of each target involved. The results from in vitro (panel of pancreatic tumor cells) and in vivo experiments (C57BL/6 bearing KP02 tumor), suggest that while the multifunctional activity was not required for the antitumor activity of these thiosemicarbazones, σ2-targeting appeared to allow alternative tumor cell death mechanisms, leading to potent and less toxic off-targets toxicities compared to other thiosemicarbazones devoid of σ2-targeting.
View MoreZhejiang Homart Chemical & Technology Co., Ltd.(expird)
Contact:13587107601
Address:Cuijiatianpu,Quzhou, Zhejiang, China (Mainland)
Hunan Dinuo Pharmaceutical Co.,Ltd.
Contact:86-731-88280100*8561
Address:Bio-pharmaceutical industrial park, Liuyang, Hunan, China
Contact:+86-731-84427351
Address:154 JIANXIANG SOUTH ROAD
Contact:86-10-62983737; +86-10-51287608
Address:4/F Building C, 2 Shangdi Xinxi Road
Fujian Xianyangyang Biotechnology Inc.
Contact:86-593-2805888
Address:No.23 Ningchuan North Road, Ningde, Fujian, China
Doi:10.1002/hlca.19800630408
(1980)Doi:10.1002/hlca.19490320122
(1949)Doi:10.1021/jo00333a003
(1981)Doi:10.1139/v87-448
(1987)Doi:10.1016/S0960-894X(01)00499-1
(2001)Doi:10.1007/BF00503479
(1981)